Skip to main content
Equibles

Invesco Ltd.

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 914208 Atlanta, GA
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$311,516
+$4,884 QoQ
Shares Held
38,891
+1.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 208 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 96% None 4%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. SPRY ranks #217 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in SPRY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $311,516 38,891
2026-03-31 $306,632 38,186
2025-12-31 $433,728 37,230
2025-09-30 $403,094 40,109
2025-06-30 $2,050,374 117,500
2025-03-31 $376,756 29,949
2024-12-31 $210,872 19,988
2024-09-30 $1,821,358 125,611
2024-06-30 $3,579,092 420,575
2024-03-31 $4,204,221 411,372
2023-12-31 $79,760 14,555
2023-09-30 $48,597 12,857
2023-06-30 $85,604 12,777
2023-03-31 $1,607,898 246,989
2022-12-31 $1,628,052 190,862